Premaitha Health CEO receives industry accolade
Yourgene Health
0.52p
17:15 07/09/23
Molecular diagnostics group Premaitha Health confirmed on Friday that its CEO, Dr Stephen Little, has received Bionow's ‘Outstanding Contribution’ award in recognition of his "significant contribution to the biomedical sector”.
FTSE AIM All-Share
745.67
17:08 19/04/24
Pharmaceuticals & Biotechnology
21,247.91
17:09 19/04/24
The AIM-traded company described Bionow as an organisation which supports business growth, competitiveness and innovation within the biomedical and life science sectors across the north of England.
Its board said Dr Little is a biotechnology entrepreneur, “industry pioneer” and an expert in the development and commercialisation of molecular diagnostics.
The directors added that he is a “passionate advocate” for Manchester and the North West as an ideal location for biotechnology companies, and a “highly respected personality” both within the region and throughout the global diagnostics industry.
“Dr Little is unquestionably one of the most successful entrepreneurs in our sector and he thoroughly deserves recognition for what he has achieved,” said Bionow CEO Dr Geoff Davison.
Dr Little himself said: that he was “honoured” to win the award, and was very proud that the Premaitha team had developed a product that was enabling “widescale uptake” of its “more accurate and reliable” screening method by allowing clinical laboratories to offer NIPT in-house.
“The result is that more and more women around the world to have access to a safe, fast and accurate test that can reduce the number of unnecessary invasive diagnostic tests, with their associated risks.
“I am grateful to Bionow for this award.”